Literature DB >> 12061361

Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin.

V Christmann1, K D Liem, B A Semmekrot, M van de Bor.   

Abstract

UNLABELLED: Vasoconstriction induced by bolus injection of indomethacin reduces organ perfusion and has been related to the well-known side effects of indomethacin given for closure of the patent ductus arteriosus (PDA). The aim of the study was to compare the changes in cerebral, renal and mesenteric blood flow velocities after continuous infusion versus bolus injection of indomethacin for closure of the PDA. Thirty-two preterm infants (range 26-35 wk gestational age) with PDA were randomly assigned to receive the same amount of indomethacin either as three bolus injections (n = 14) or as a continuous infusion (n = 18) over 36 h. Blood flow velocities were measured in the internal carotid, right renal and superior mesenteric arteries at baseline and serially at 10, 30, 60 and 120 min and 12, 24, 36 and 48 h after the start of indomethacin treatment. There were no differences in blood flow velocities between both groups at baseline. During continuous infusion of indomethacin there was no significant change in the cerebral, renal and mesenteric blood flow velocities, whereas the flow velocities in the infants receiving bolus injections decreased significantly during the first 2 h after indomethacin administration in all arteries measured. There was a transient, but significant reduction in urine output after bolus injection of indomethacin.
CONCLUSION: In contrast to bolus injections, decrease of organ blood flow and impairment of urine output do not accompany continuous infusion of indomethacin over 36 h.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061361     DOI: 10.1080/080352502317371698

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  19 in total

Review 1.  Patent ductus arteriosus: lack of evidence for common treatments.

Authors:  Carl L Bose; Matthew M Laughon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

2.  Neonatal colour Doppler ultrasound study: normal values of abdominal blood flow velocities in the neonate during the first month of life.

Authors:  Patrizia Papacci; Carmen Giannantonio; Francesco Cota; Caterina Latella; Carla Maria Semeraro; Maria Fioretti; Mikael Ghennet Tesfagabir; Costantino Romagnoli
Journal:  Pediatr Radiol       Date:  2009-02-03

3.  Enteral feeding during indomethacin treatment for patent ductus arteriosus: association with gastrointestinal outcomes.

Authors:  D Louis; R Torgalkar; J Shah; P S Shah; A Jain
Journal:  J Perinatol       Date:  2016-02-25       Impact factor: 2.521

Review 4.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

5.  Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

6.  Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone.

Authors:  Elaine L Shelton; Gerren Ector; Cristi L Galindo; Christopher W Hooper; Naoko Brown; Irene Wilkerson; Elise R Pfaltzgraff; Bibhash C Paria; Robert B Cotton; Jason Z Stoller; Jeff Reese
Journal:  Physiol Genomics       Date:  2014-05-01       Impact factor: 3.107

Review 7.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

Review 8.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

9.  Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus.

Authors:  Ronald Clyman; Andrea Wickremasinghe; Nami Jhaveri; Denise C Hassinger; Joshua T Attridge; Ulana Sanocka; Richard Polin; Maria Gillam-Krakauer; Jeff Reese; Mark Mammel; Robert Couser; Neil Mulrooney; Toby D Yanowitz; Matthew Derrick; Priya Jegatheesan; Michele Walsh; Alan Fujii; Nicolas Porta; William A Carey; Jonathan R Swanson
Journal:  J Pediatr       Date:  2013-03-06       Impact factor: 4.406

10.  Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.

Authors:  Hussnain Mirza; Abbot R Laptook; William Oh; Betty R Vohr; Barbara J Stoll; Sarah Kandefer; Barbara S Stonestreet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-01-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.